A Phase 1, Double-blind, Single Center, Controlled Study to Evaluate the Safety and Tolerability of FSR Peptide Versus Placebo Following Punch Biopsy in Adult Healthy Volunteers
Latest Information Update: 09 Jun 2022
At a glance
- Drugs ACT 1 (Primary)
- Indications Wounds
- Focus Adverse reactions
- Sponsors Xequel Bio
- 24 Jul 2020 New trial record